cdna synthesis Search Results


95
PCR Biosystems Ltd ultrascript cdna synthesis kit
Ultrascript Cdna Synthesis Kit, supplied by PCR Biosystems Ltd, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ultrascript cdna synthesis kit/product/PCR Biosystems Ltd
Average 95 stars, based on 1 article reviews
ultrascript cdna synthesis kit - by Bioz Stars, 2026-05
95/100 stars
  Buy from Supplier

96
PCR Biosystems Ltd qpcrbio cdna synthesis kit
Qpcrbio Cdna Synthesis Kit, supplied by PCR Biosystems Ltd, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/qpcrbio cdna synthesis kit/product/PCR Biosystems Ltd
Average 96 stars, based on 1 article reviews
qpcrbio cdna synthesis kit - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

93
Solis BioDyne rt cdna synthesis kit
Rt Cdna Synthesis Kit, supplied by Solis BioDyne, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rt cdna synthesis kit/product/Solis BioDyne
Average 93 stars, based on 1 article reviews
rt cdna synthesis kit - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

96
New England Biolabs protoscript first strand cdna synthesis kit
a , Summary of EBV DNA ddPCR results from CSF supernatant in which EBER2 was normalized to a housekeeping gene (MS/CIS, n = 13; HC/OND, n = 5). b , EBV <t>cDNA</t> for each of the indicated genes were measured by ddPCR and normalized to a housekeeping gene. Each sample was run in duplicate and each dot represents the average result from each study participant. Data are the mean ± s.e.m. MS/CIS and HC/OND samples were compared using an unpaired two-tailed Student’s t -test with Welch’s correction; NS, not significant; n = 13 for MS/CIS for all genes except EBER2 where n = 12 due to lack of sufficient sample for MS27 and n = 5 in HC/OND for all genes except BamHI-W where n = 4 due to a lack of sufficient sample for OND4.
Protoscript First Strand Cdna Synthesis Kit, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/protoscript first strand cdna synthesis kit/product/New England Biolabs
Average 96 stars, based on 1 article reviews
protoscript first strand cdna synthesis kit - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

99
Bio-Rad iscripttm gdna clear cdna synthesis kit
a , Summary of EBV DNA ddPCR results from CSF supernatant in which EBER2 was normalized to a housekeeping gene (MS/CIS, n = 13; HC/OND, n = 5). b , EBV <t>cDNA</t> for each of the indicated genes were measured by ddPCR and normalized to a housekeeping gene. Each sample was run in duplicate and each dot represents the average result from each study participant. Data are the mean ± s.e.m. MS/CIS and HC/OND samples were compared using an unpaired two-tailed Student’s t -test with Welch’s correction; NS, not significant; n = 13 for MS/CIS for all genes except EBER2 where n = 12 due to lack of sufficient sample for MS27 and n = 5 in HC/OND for all genes except BamHI-W where n = 4 due to a lack of sufficient sample for OND4.
Iscripttm Gdna Clear Cdna Synthesis Kit, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/iscripttm gdna clear cdna synthesis kit/product/Bio-Rad
Average 99 stars, based on 1 article reviews
iscripttm gdna clear cdna synthesis kit - by Bioz Stars, 2026-05
99/100 stars
  Buy from Supplier

96
Illumina Inc ampliseq cdna synthesis for illumina
Figure 1 Multi-omic analysis of matched liver and plasma samples. (a) The experimental workflow started at collection of matched liver and blood samples from the same patients. Blood was fractionated to isolate plasma, followed by isolation of exosomes and extraction of cell-free RNA (cfRNA), which was analyzed by next generation sequencing (NGS). Tissue was homogenized and processed by differential centrifugation to extract membrane fractions, followed by proteolysis of membrane proteins and mass spectrometric analysis. (b) Exosomal pellets extracted from plasma by polymer-assisted precipitation were visually inspected and examined by transmission electron microscopy (×13,000). (c) The yields of cfRNA (from each sample) and corresponding reverse transcribed <t>cDNA</t> were assessed, which reflected variability between samples. (d) Sequencing quality was examined, reflecting high quality scores (Q-scores). (e) For tissue processing, the level of membrane recovery (mean ± SE of the mean) was assessed using resident markers of endoplasmic reticulum and plasma membranes. (f) Proteomic analysis by mass spectrometry generated peptide and protein data, reflecting consistently high numbers of identified peptides and on average similar numbers of proteins (mean ± SD). (g) Protein identification was carried out with a sufficient number of peptides per protein (mean ± SD). (h) Quantification of proteins was possible for 84% of identified proteins using global proteomic data (n = 2,143), spanning 5 orders of magnitude. Of these, targeted measurement of eight enzymes, four transferases, and four transporters was possible using signature peptide data relative to QconCAT standard; the rank order of key target proteins is shown.
Ampliseq Cdna Synthesis For Illumina, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ampliseq cdna synthesis for illumina/product/Illumina Inc
Average 96 stars, based on 1 article reviews
ampliseq cdna synthesis for illumina - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

96
tiangen biotech co mirna cdna first strand synthesis kit
Figure 1 Multi-omic analysis of matched liver and plasma samples. (a) The experimental workflow started at collection of matched liver and blood samples from the same patients. Blood was fractionated to isolate plasma, followed by isolation of exosomes and extraction of cell-free RNA (cfRNA), which was analyzed by next generation sequencing (NGS). Tissue was homogenized and processed by differential centrifugation to extract membrane fractions, followed by proteolysis of membrane proteins and mass spectrometric analysis. (b) Exosomal pellets extracted from plasma by polymer-assisted precipitation were visually inspected and examined by transmission electron microscopy (×13,000). (c) The yields of cfRNA (from each sample) and corresponding reverse transcribed <t>cDNA</t> were assessed, which reflected variability between samples. (d) Sequencing quality was examined, reflecting high quality scores (Q-scores). (e) For tissue processing, the level of membrane recovery (mean ± SE of the mean) was assessed using resident markers of endoplasmic reticulum and plasma membranes. (f) Proteomic analysis by mass spectrometry generated peptide and protein data, reflecting consistently high numbers of identified peptides and on average similar numbers of proteins (mean ± SD). (g) Protein identification was carried out with a sufficient number of peptides per protein (mean ± SD). (h) Quantification of proteins was possible for 84% of identified proteins using global proteomic data (n = 2,143), spanning 5 orders of magnitude. Of these, targeted measurement of eight enzymes, four transferases, and four transporters was possible using signature peptide data relative to QconCAT standard; the rank order of key target proteins is shown.
Mirna Cdna First Strand Synthesis Kit, supplied by tiangen biotech co, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mirna cdna first strand synthesis kit/product/tiangen biotech co
Average 96 stars, based on 1 article reviews
mirna cdna first strand synthesis kit - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

98
New England Biolabs protoscript ii first strand cdna synthesis kit
Figure 1 Multi-omic analysis of matched liver and plasma samples. (a) The experimental workflow started at collection of matched liver and blood samples from the same patients. Blood was fractionated to isolate plasma, followed by isolation of exosomes and extraction of cell-free RNA (cfRNA), which was analyzed by next generation sequencing (NGS). Tissue was homogenized and processed by differential centrifugation to extract membrane fractions, followed by proteolysis of membrane proteins and mass spectrometric analysis. (b) Exosomal pellets extracted from plasma by polymer-assisted precipitation were visually inspected and examined by transmission electron microscopy (×13,000). (c) The yields of cfRNA (from each sample) and corresponding reverse transcribed <t>cDNA</t> were assessed, which reflected variability between samples. (d) Sequencing quality was examined, reflecting high quality scores (Q-scores). (e) For tissue processing, the level of membrane recovery (mean ± SE of the mean) was assessed using resident markers of endoplasmic reticulum and plasma membranes. (f) Proteomic analysis by mass spectrometry generated peptide and protein data, reflecting consistently high numbers of identified peptides and on average similar numbers of proteins (mean ± SD). (g) Protein identification was carried out with a sufficient number of peptides per protein (mean ± SD). (h) Quantification of proteins was possible for 84% of identified proteins using global proteomic data (n = 2,143), spanning 5 orders of magnitude. Of these, targeted measurement of eight enzymes, four transferases, and four transporters was possible using signature peptide data relative to QconCAT standard; the rank order of key target proteins is shown.
Protoscript Ii First Strand Cdna Synthesis Kit, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/protoscript ii first strand cdna synthesis kit/product/New England Biolabs
Average 98 stars, based on 1 article reviews
protoscript ii first strand cdna synthesis kit - by Bioz Stars, 2026-05
98/100 stars
  Buy from Supplier

97
Quanta Biosciences qscript cdna synthesis kit
Figure 1 Multi-omic analysis of matched liver and plasma samples. (a) The experimental workflow started at collection of matched liver and blood samples from the same patients. Blood was fractionated to isolate plasma, followed by isolation of exosomes and extraction of cell-free RNA (cfRNA), which was analyzed by next generation sequencing (NGS). Tissue was homogenized and processed by differential centrifugation to extract membrane fractions, followed by proteolysis of membrane proteins and mass spectrometric analysis. (b) Exosomal pellets extracted from plasma by polymer-assisted precipitation were visually inspected and examined by transmission electron microscopy (×13,000). (c) The yields of cfRNA (from each sample) and corresponding reverse transcribed <t>cDNA</t> were assessed, which reflected variability between samples. (d) Sequencing quality was examined, reflecting high quality scores (Q-scores). (e) For tissue processing, the level of membrane recovery (mean ± SE of the mean) was assessed using resident markers of endoplasmic reticulum and plasma membranes. (f) Proteomic analysis by mass spectrometry generated peptide and protein data, reflecting consistently high numbers of identified peptides and on average similar numbers of proteins (mean ± SD). (g) Protein identification was carried out with a sufficient number of peptides per protein (mean ± SD). (h) Quantification of proteins was possible for 84% of identified proteins using global proteomic data (n = 2,143), spanning 5 orders of magnitude. Of these, targeted measurement of eight enzymes, four transferases, and four transporters was possible using signature peptide data relative to QconCAT standard; the rank order of key target proteins is shown.
Qscript Cdna Synthesis Kit, supplied by Quanta Biosciences, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/qscript cdna synthesis kit/product/Quanta Biosciences
Average 97 stars, based on 1 article reviews
qscript cdna synthesis kit - by Bioz Stars, 2026-05
97/100 stars
  Buy from Supplier

96
TaKaRa cdna synthesis utilized prime script rt reagent kit
Figure 1 Multi-omic analysis of matched liver and plasma samples. (a) The experimental workflow started at collection of matched liver and blood samples from the same patients. Blood was fractionated to isolate plasma, followed by isolation of exosomes and extraction of cell-free RNA (cfRNA), which was analyzed by next generation sequencing (NGS). Tissue was homogenized and processed by differential centrifugation to extract membrane fractions, followed by proteolysis of membrane proteins and mass spectrometric analysis. (b) Exosomal pellets extracted from plasma by polymer-assisted precipitation were visually inspected and examined by transmission electron microscopy (×13,000). (c) The yields of cfRNA (from each sample) and corresponding reverse transcribed <t>cDNA</t> were assessed, which reflected variability between samples. (d) Sequencing quality was examined, reflecting high quality scores (Q-scores). (e) For tissue processing, the level of membrane recovery (mean ± SE of the mean) was assessed using resident markers of endoplasmic reticulum and plasma membranes. (f) Proteomic analysis by mass spectrometry generated peptide and protein data, reflecting consistently high numbers of identified peptides and on average similar numbers of proteins (mean ± SD). (g) Protein identification was carried out with a sufficient number of peptides per protein (mean ± SD). (h) Quantification of proteins was possible for 84% of identified proteins using global proteomic data (n = 2,143), spanning 5 orders of magnitude. Of these, targeted measurement of eight enzymes, four transferases, and four transporters was possible using signature peptide data relative to QconCAT standard; the rank order of key target proteins is shown.
Cdna Synthesis Utilized Prime Script Rt Reagent Kit, supplied by TaKaRa, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cdna synthesis utilized prime script rt reagent kit/product/TaKaRa
Average 96 stars, based on 1 article reviews
cdna synthesis utilized prime script rt reagent kit - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

99
TaKaRa primescript ii 1st strand cdna synthesis kit
Figure 1 Multi-omic analysis of matched liver and plasma samples. (a) The experimental workflow started at collection of matched liver and blood samples from the same patients. Blood was fractionated to isolate plasma, followed by isolation of exosomes and extraction of cell-free RNA (cfRNA), which was analyzed by next generation sequencing (NGS). Tissue was homogenized and processed by differential centrifugation to extract membrane fractions, followed by proteolysis of membrane proteins and mass spectrometric analysis. (b) Exosomal pellets extracted from plasma by polymer-assisted precipitation were visually inspected and examined by transmission electron microscopy (×13,000). (c) The yields of cfRNA (from each sample) and corresponding reverse transcribed <t>cDNA</t> were assessed, which reflected variability between samples. (d) Sequencing quality was examined, reflecting high quality scores (Q-scores). (e) For tissue processing, the level of membrane recovery (mean ± SE of the mean) was assessed using resident markers of endoplasmic reticulum and plasma membranes. (f) Proteomic analysis by mass spectrometry generated peptide and protein data, reflecting consistently high numbers of identified peptides and on average similar numbers of proteins (mean ± SD). (g) Protein identification was carried out with a sufficient number of peptides per protein (mean ± SD). (h) Quantification of proteins was possible for 84% of identified proteins using global proteomic data (n = 2,143), spanning 5 orders of magnitude. Of these, targeted measurement of eight enzymes, four transferases, and four transporters was possible using signature peptide data relative to QconCAT standard; the rank order of key target proteins is shown.
Primescript Ii 1st Strand Cdna Synthesis Kit, supplied by TaKaRa, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primescript ii 1st strand cdna synthesis kit/product/TaKaRa
Average 99 stars, based on 1 article reviews
primescript ii 1st strand cdna synthesis kit - by Bioz Stars, 2026-05
99/100 stars
  Buy from Supplier

98
Vazyme Biotech Co mirna 1st strand cdna synthesis kit
Figure 1 Multi-omic analysis of matched liver and plasma samples. (a) The experimental workflow started at collection of matched liver and blood samples from the same patients. Blood was fractionated to isolate plasma, followed by isolation of exosomes and extraction of cell-free RNA (cfRNA), which was analyzed by next generation sequencing (NGS). Tissue was homogenized and processed by differential centrifugation to extract membrane fractions, followed by proteolysis of membrane proteins and mass spectrometric analysis. (b) Exosomal pellets extracted from plasma by polymer-assisted precipitation were visually inspected and examined by transmission electron microscopy (×13,000). (c) The yields of cfRNA (from each sample) and corresponding reverse transcribed <t>cDNA</t> were assessed, which reflected variability between samples. (d) Sequencing quality was examined, reflecting high quality scores (Q-scores). (e) For tissue processing, the level of membrane recovery (mean ± SE of the mean) was assessed using resident markers of endoplasmic reticulum and plasma membranes. (f) Proteomic analysis by mass spectrometry generated peptide and protein data, reflecting consistently high numbers of identified peptides and on average similar numbers of proteins (mean ± SD). (g) Protein identification was carried out with a sufficient number of peptides per protein (mean ± SD). (h) Quantification of proteins was possible for 84% of identified proteins using global proteomic data (n = 2,143), spanning 5 orders of magnitude. Of these, targeted measurement of eight enzymes, four transferases, and four transporters was possible using signature peptide data relative to QconCAT standard; the rank order of key target proteins is shown.
Mirna 1st Strand Cdna Synthesis Kit, supplied by Vazyme Biotech Co, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mirna 1st strand cdna synthesis kit/product/Vazyme Biotech Co
Average 98 stars, based on 1 article reviews
mirna 1st strand cdna synthesis kit - by Bioz Stars, 2026-05
98/100 stars
  Buy from Supplier

Image Search Results


a , Summary of EBV DNA ddPCR results from CSF supernatant in which EBER2 was normalized to a housekeeping gene (MS/CIS, n = 13; HC/OND, n = 5). b , EBV cDNA for each of the indicated genes were measured by ddPCR and normalized to a housekeeping gene. Each sample was run in duplicate and each dot represents the average result from each study participant. Data are the mean ± s.e.m. MS/CIS and HC/OND samples were compared using an unpaired two-tailed Student’s t -test with Welch’s correction; NS, not significant; n = 13 for MS/CIS for all genes except EBER2 where n = 12 due to lack of sufficient sample for MS27 and n = 5 in HC/OND for all genes except BamHI-W where n = 4 due to a lack of sufficient sample for OND4.

Journal: Nature Immunology

Article Title: Antigen specificity of clonally enriched CD8 + T cells in multiple sclerosis

doi: 10.1038/s41590-025-02412-3

Figure Lengend Snippet: a , Summary of EBV DNA ddPCR results from CSF supernatant in which EBER2 was normalized to a housekeeping gene (MS/CIS, n = 13; HC/OND, n = 5). b , EBV cDNA for each of the indicated genes were measured by ddPCR and normalized to a housekeeping gene. Each sample was run in duplicate and each dot represents the average result from each study participant. Data are the mean ± s.e.m. MS/CIS and HC/OND samples were compared using an unpaired two-tailed Student’s t -test with Welch’s correction; NS, not significant; n = 13 for MS/CIS for all genes except EBER2 where n = 12 due to lack of sufficient sample for MS27 and n = 5 in HC/OND for all genes except BamHI-W where n = 4 due to a lack of sufficient sample for OND4.

Article Snippet: Complementary DNA was synthesized using a ProtoScript first strand cDNA synthesis kit (NEB) using 6 μl RNA per 20 μl reaction volume according to the manufacturer’s instructions.

Techniques: Two Tailed Test

Figure 1 Multi-omic analysis of matched liver and plasma samples. (a) The experimental workflow started at collection of matched liver and blood samples from the same patients. Blood was fractionated to isolate plasma, followed by isolation of exosomes and extraction of cell-free RNA (cfRNA), which was analyzed by next generation sequencing (NGS). Tissue was homogenized and processed by differential centrifugation to extract membrane fractions, followed by proteolysis of membrane proteins and mass spectrometric analysis. (b) Exosomal pellets extracted from plasma by polymer-assisted precipitation were visually inspected and examined by transmission electron microscopy (×13,000). (c) The yields of cfRNA (from each sample) and corresponding reverse transcribed cDNA were assessed, which reflected variability between samples. (d) Sequencing quality was examined, reflecting high quality scores (Q-scores). (e) For tissue processing, the level of membrane recovery (mean ± SE of the mean) was assessed using resident markers of endoplasmic reticulum and plasma membranes. (f) Proteomic analysis by mass spectrometry generated peptide and protein data, reflecting consistently high numbers of identified peptides and on average similar numbers of proteins (mean ± SD). (g) Protein identification was carried out with a sufficient number of peptides per protein (mean ± SD). (h) Quantification of proteins was possible for 84% of identified proteins using global proteomic data (n = 2,143), spanning 5 orders of magnitude. Of these, targeted measurement of eight enzymes, four transferases, and four transporters was possible using signature peptide data relative to QconCAT standard; the rank order of key target proteins is shown.

Journal: Clinical pharmacology and therapeutics

Article Title: Liquid Biopsy Enables Quantification of the Abundance and Interindividual Variability of Hepatic Enzymes and Transporters.

doi: 10.1002/cpt.2102

Figure Lengend Snippet: Figure 1 Multi-omic analysis of matched liver and plasma samples. (a) The experimental workflow started at collection of matched liver and blood samples from the same patients. Blood was fractionated to isolate plasma, followed by isolation of exosomes and extraction of cell-free RNA (cfRNA), which was analyzed by next generation sequencing (NGS). Tissue was homogenized and processed by differential centrifugation to extract membrane fractions, followed by proteolysis of membrane proteins and mass spectrometric analysis. (b) Exosomal pellets extracted from plasma by polymer-assisted precipitation were visually inspected and examined by transmission electron microscopy (×13,000). (c) The yields of cfRNA (from each sample) and corresponding reverse transcribed cDNA were assessed, which reflected variability between samples. (d) Sequencing quality was examined, reflecting high quality scores (Q-scores). (e) For tissue processing, the level of membrane recovery (mean ± SE of the mean) was assessed using resident markers of endoplasmic reticulum and plasma membranes. (f) Proteomic analysis by mass spectrometry generated peptide and protein data, reflecting consistently high numbers of identified peptides and on average similar numbers of proteins (mean ± SD). (g) Protein identification was carried out with a sufficient number of peptides per protein (mean ± SD). (h) Quantification of proteins was possible for 84% of identified proteins using global proteomic data (n = 2,143), spanning 5 orders of magnitude. Of these, targeted measurement of eight enzymes, four transferases, and four transporters was possible using signature peptide data relative to QconCAT standard; the rank order of key target proteins is shown.

Article Snippet: Reverse transcription was performed with 3.5 μl of isolated cfRNA using AmpliSeq cDNA Synthesis for Illumina (Cambridge, UK).

Techniques: Clinical Proteomics, Isolation, Extraction, Next-Generation Sequencing, Centrifugation, Membrane, Polymer, Transmission Assay, Electron Microscopy, Reverse Transcription, Sequencing, Mass Spectrometry, Generated